LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2019 Apr 19

PMID 30995715

Citations 27

Authors

Laura Bonanno

Elisabetta Zulato

Alberto Pavan

Ilaria Attili

Giulia Pasello

Pierfranco Conte

Stefano Indraccolo

Affiliations

Soon will be listed here.

Abstract

Liver kinase B1 () is a tumor suppressor gene whose inactivation is frequent in different tumor types, especially in lung adenocarcinoma (about 30% of cases). LKB1 has an essential role in the control of cellular redox homeostasis by regulating ROS production and detoxification. Loss of LKB1 makes the tumor cell more sensitive to oxidative stress and consequently to stress-inducing treatments, such as chemotherapy and radiotherapy. LKB1 loss triggers complex changes in tumor microenvironment, supporting a role in the regulation of angiogenesis and suggesting a potential role in the response to anti-angiogenic treatment. On the other hand, LKB1 deficiency can promote an immunosuppressive microenvironment and may be involved in primary resistance to anti-PD-1/anti-PD-L1, as it has been reported in lung cancer. The aim of this review is to discuss interactions of LKB1 with the tumor microenvironment and the potential applications of this knowledge in predicting response to treatment in lung cancer.

Citing Articles

Molecular mechanism of genetic, epigenetic, and metabolic alteration in lung cancer.

Fatima S, Kumar V, Kumar D Med Oncol. 2025; 42(3):61.

PMID: 39893601 DOI: 10.1007/s12032-025-02608-5.

FBXL19 Targeted STK11 Degradation Enhances Cigarette Smoke-Induced Airway Epithelial Cell Cytotoxicity.

Li X, Lakshmi S, Uemasu K, Lane Z, Reddy R, Chandra D COPD. 2024; 21(1):2342797.

PMID: 38712759 PMC: 11186665. DOI: 10.1080/15412555.2024.2342797.

Inhibition of ERO1a and IDO1 improves dendritic cell infiltration into pancreatic ductal adenocarcinoma.

Tay A, Cinotti R, Sze N, Lundqvist A Front Immunol. 2024; 14:1264012.

PMID: 38187398 PMC: 10766682. DOI: 10.3389/fimmu.2023.1264012.

Efficacy and safety of EGFR-TKIs in combination with angiogenesis inhibitors as first-line therapy for advanced EGFR-mutant non-small-cell lung cancer: a systematic review and meta-analysis.

Hu D, Zhou Y, Ma H, Tao M, Huang Q, Yang Z BMC Pulm Med. 2023; 23(1):207.

PMID: 37316870 PMC: 10268338. DOI: 10.1186/s12890-023-02472-x.

Clinicopathological and prognostic significance of LKB1 expression in gastric cancer: a systematic review and meta-analysis.

Tan G, Liu B Sci Rep. 2023; 13(1):8937.

PMID: 37264076 PMC: 10235053. DOI: 10.1038/s41598-023-36239-5.

References

Guldberg P, Thor Straten P, Ahrenkiel V, Seremet T, Kirkin A, Zeuthen J . Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma. Oncogene. 1999; 18(9):1777-80. DOI: 10.1038/sj.onc.1202486. View

Hemminki A . The molecular basis and clinical aspects of Peutz-Jeghers syndrome. Cell Mol Life Sci. 1999; 55(5):735-50. PMC: 11146769. DOI: 10.1007/s000180050329. View

El-Mir M, Nogueira V, Fontaine E, Averet N, Rigoulet M, Leverve X . Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem. 2000; 275(1):223-8. DOI: 10.1074/jbc.275.1.223. View

Miao H, Klagsbrun M . Neuropilin is a mediator of angiogenesis. Cancer Metastasis Rev. 2001; 19(1-2):29-37. DOI: 10.1023/a:1026579711033. View

Kawaguchi T, Osatomi K, Yamashita H, Kabashima T, Uyeda K . Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase. J Biol Chem. 2001; 277(6):3829-35. DOI: 10.1074/jbc.M107895200. View

Arbiser J, Brat D, Hunter S, DArmiento J, Henske E, Arbiser Z . Tuberous sclerosis-associated lesions of the kidney, brain, and skin are angiogenic neoplasms. J Am Acad Dermatol. 2002; 46(3):376-80. DOI: 10.1067/mjd.2002.120530. View

Huang S, Bucana C, Van Arsdall M, Fidler I . Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells. Oncogene. 2002; 21(16):2504-12. DOI: 10.1038/sj.onc.1205341. View

Shen Z, Wen X, Lan F, Shen Z, Shao Z . The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma. Clin Cancer Res. 2002; 8(7):2085-90. View

Sapkota G, Deak M, Kieloch A, Morrice N, Goodarzi A, Smythe C . Ionizing radiation induces ataxia telangiectasia mutated kinase (ATM)-mediated phosphorylation of LKB1/STK11 at Thr-366. Biochem J. 2002; 368(Pt 2):507-16. PMC: 1223019. DOI: 10.1042/BJ20021284. View

10.

Ohm J, Gabrilovich D, Sempowski G, Kisseleva E, Parman K, Nadaf S . VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression. Blood. 2003; 101(12):4878-86. DOI: 10.1182/blood-2002-07-1956. View

11.

Hong Y, Varanasi U, Yang W, Leff T . AMP-activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability. J Biol Chem. 2003; 278(30):27495-501. DOI: 10.1074/jbc.M304112200. View

12.

Parker L, Piwnica-Worms H . Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science. 1992; 257(5078):1955-7. DOI: 10.1126/science.1384126. View

13.

Woods A, Johnstone S, Dickerson K, Leiper F, Fryer L, Neumann D . LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol. 2003; 13(22):2004-8. DOI: 10.1016/j.cub.2003.10.031. View

14.

Lizcano J, Goransson O, Toth R, Deak M, Morrice N, Boudeau J . LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 2004; 23(4):833-43. PMC: 381014. DOI: 10.1038/sj.emboj.7600110. View

15.

Shaw R, Kosmatka M, Bardeesy N, Hurley R, Witters L, DePinho R . The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A. 2004; 101(10):3329-35. PMC: 373461. DOI: 10.1073/pnas.0308061100. View

16.

Fernandes N, Sun Y, Chen S, Paul P, Shaw R, Cantley L . DNA damage-induced association of ATM with its target proteins requires a protein interaction domain in the N terminus of ATM. J Biol Chem. 2005; 280(15):15158-64. DOI: 10.1074/jbc.M412065200. View

17.

Kim J, Tchernyshyov I, Semenza G, Dang C . HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006; 3(3):177-85. DOI: 10.1016/j.cmet.2006.02.002. View

18.

Zhuang Z, Di G, Shen Z, Ding J, Shao Z . Enhanced expression of LKB1 in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential. Mol Cancer Res. 2006; 4(11):843-9. DOI: 10.1158/1541-7786.MCR-06-0118. View

19.

Bouzin C, Brouet A, De Vriese J, Dewever J, Feron O . Effects of vascular endothelial growth factor on the lymphocyte-endothelium interactions: identification of caveolin-1 and nitric oxide as control points of endothelial cell anergy. J Immunol. 2007; 178(3):1505-11. DOI: 10.4049/jimmunol.178.3.1505. View

20.

Beckers A, Organe S, Timmermans L, Scheys K, Peeters A, Brusselmans K . Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells. Cancer Res. 2007; 67(17):8180-7. DOI: 10.1158/0008-5472.CAN-07-0389. View